IMBIV   05474
INSTITUTO MULTIDISCIPLINARIO DE BIOLOGIA VEGETAL
Unidad Ejecutora - UE
artículos
Título:
Neuroprotective effects of prenylated flavanones isolated from Dalea species, in vitro and in silico studies
Autor/es:
ARREDONDO, FLORENCIA; PRUNELL, GISELLE; ORTEGA, MARÍA G.; SANTI, MARÍA D.; ECHEVERRY, CAROLINA; CABRERA, JOSÉ L.; ABIN-CARRIQUIRY, JUAN A.; CARVALHO, DIEGO; PERALTA, MARIANA A.; SAVIO, EDUARDO; ARREDONDO, FLORENCIA; PRUNELL, GISELLE; ORTEGA, MARÍA G.; SANTI, MARÍA D.; ECHEVERRY, CAROLINA; CABRERA, JOSÉ L.; ABIN-CARRIQUIRY, JUAN A.; CARVALHO, DIEGO; PERALTA, MARIANA A.; SAVIO, EDUARDO
Revista:
EUROPEAN JOURNAL OF MEDICAL CHEMISTRY
Editorial:
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
Referencias:
Lugar: Paris; Año: 2020 vol. 206
ISSN:
0223-5234
Resumen:
Neurodegenerative diseases (NDs) represent a global problem on public health, with a growing incidence as human longevity increases. Currently, although there are palliative strategies available for most of these diseases, there is a lack of effective therapies for their cure. Flavonoids are extensively studied for their multi-target behavior. Among numerous biological activities, it has been reported that they act at the CNS level, presenting neuroprotective activity through different mechanisms of action. Dalea L. (Fabaceae) is an American genus, with about 172 species. Dalea elegans Gillies ex. Hook. & Arn and Dalea pazensis Rusby, both South American species, are the important source of natural compounds of the prenylated flavanones type. In the present study, five prenylated flavanones isolated from Dalea species were assayed for their neuroprotective activity in two in vitro models of neurodegeneration. Flavanones 1 and 2 exhibited neuroprotective effects against oxidative stress-induced death in both models, granular cerebellar neurons and (NGF)-differentiated PC12 cells. Structure-activity relationships were also reported. Our results indicated that an 8-prenyl group at the A-ring accompanied by an unsubstituted B-ring, or a 2?,4?-dihydroxy-5?-dimethylallyl substitution, lead to the most potent flavanones. Furthermore, in silico studies were performed, and several putative targets in NDs were identified for compounds 1 and 2. Between them, the enzyme acetylcholinesterase was selected for its validation in vitro. The present in vitro and in silico results imply that prenylated flavanones 1 and 2 may be useful in the development and design of future strategies for the treatment of NDs diseases.